The first Ambrx Biopharma trade was made in Q3 2022.
Since then Ken Griffin bought shares three more times and sold shares on two occasions. The investor sold all their shares in Q4 2023 and doesn't own any shares in Ambrx Biopharma anymore.
Avg closing price
Price range
Sold -769 Thousand shares
Q4 2023
Avg closing price
$11.36
Price range
$8.40
-
$14.96
Increased shares by 5.7% (+41.8 Thousand shares)
Q3 2023
Avg closing price
$13.62
Price range
$9.30
-
$16.60
Increased shares by 2.8% (+19.9 Thousand shares)
Q2 2023
Avg closing price
$12.57
Price range
$7.66
-
$16.46
Increased shares by 16107.5% (+703 Thousand shares)
Q1 2023